Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus

Fig. 4

Associations between attainment of LLDAS after 6 months and levels of a, b anti-SSA/Ro52, c, d anti-SSA/Ro60, and e, f anti-SSB/La in a, c, e sera where data were obtained with conventional measurements and b, d, f in the corresponding solubilized IC. Horizontal lines illustrate median levels, with corresponding values presented below each measure. ns not significant, LLDAS low lupus disease activity state

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us